Karabulut, S. Et Al. 2013. Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).

Karabulut, S., Ciftci, R., Sen, F., & Tas, F., (2013). Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands

Karabulut, S. Et Al. "Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013

Karabulut, S. Et Al. "Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

Karabulut, S. Et Al. (2013) . "Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={S. Karabulut Et Al. }, title={Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}